Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

Micro-PET imaging of [18F]fluoroacetate combined with [18F]FDG to differentiate chronic Mycobacterium tuberculosis infection from an acute bacterial infection in a mouse model: a preliminary study.

Tsao CH, Wu CY, Chang CW, Wang HE, Shih BF, Liu RS.

Nucl Med Commun. 2019 Jun;40(6):639-644. doi: 10.1097/MNM.0000000000001017.

PMID:
30932968
2.

Evaluation of the Biological Behavior of a Gold Nanocore-Encapsulated Human Serum Albumin Nanoparticle (Au@HSANP) in a CT-26 Tumor/Ascites Mouse Model after Intravenous/Intraperitoneal Administration.

Chen CC, Li JJ, Guo NH, Chang DY, Wang CY, Chen JT, Lin WJ, Chi KH, Lee YJ, Liu RS, Chen CL, Wang HE.

Int J Mol Sci. 2019 Jan 8;20(1). pii: E217. doi: 10.3390/ijms20010217.

3.

PEGylated liposome-encapsulated rhenium-188 radiopharmaceutical inhibits proliferation and epithelial-mesenchymal transition of human head and neck cancer cells in vivo with repeated therapy.

Chang CY, Chen CC, Lin LT, Chang CH, Chen LC, Wang HE, Lee TW, Lee YJ.

Cell Death Discov. 2018 Oct 31;4:100. doi: 10.1038/s41420-018-0116-8. eCollection 2018.

4.

Simplified quantification of 13N-ammonia PET myocardial blood flow: A comparative study with the standard compartment model to facilitate clinical use.

Chang CY, Hung GU, Hsu B, Yang BH, Chang CW, Hu LH, Huang WS, Wang HE, Wu TC, Liu RS.

J Nucl Cardiol. 2018 Oct 15. doi: 10.1007/s12350-018-1450-1. [Epub ahead of print]

PMID:
30324328
5.

Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes.

Hsieh YC, Wang HE, Lin WW, Roffler SR, Cheng TC, Su YC, Li JJ, Chen CC, Huang CH, Chen BM, Wang JY, Cheng TL, Chen FM.

Theranostics. 2018 May 9;8(11):3164-3175. doi: 10.7150/thno.22164. eCollection 2018.

6.

Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice.

Weng MC, Wang MH, Tsai JJ, Kuo YC, Liu YC, Hsu FT, Wang HE.

Biosci Rep. 2018 May 8;38(3). pii: BSR20171264. doi: 10.1042/BSR20171264. Print 2018 Jun 29.

7.

Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells.

Hsu SPC, Kuo JS, Chiang HC, Wang HE, Wang YS, Huang CC, Huang YC, Chi MS, Mehta MP, Chi KH.

Oncotarget. 2018 Jan 3;9(6):6883-6896. doi: 10.18632/oncotarget.23855. eCollection 2018 Jan 23.

8.

Dataset on the synthesis and characterization of boron fenbufen and its F-18 labeled homolog.

Yeh CN, Chang CW, Chung YH, Tien SW, Chen YR, Chen TW, Huang YC, Wang HE, Chou YC, Chen MH, Chiang KC, Huang WS, Yu CS.

Data Brief. 2017 Sep 5;15:174-202. doi: 10.1016/j.dib.2017.08.048. eCollection 2017 Dec.

9.

Synthesis and characterization of boron fenbufen and its F-18 labeled homolog for boron neutron capture therapy of COX-2 overexpressed cholangiocarcinoma.

Yeh CN, Chang CW, Chung YH, Tien SW, Chen YR, Chen TW, Huang YC, Wang HE, Chou YC, Chen MH, Chiang KC, Huang WS, Yu CS.

Eur J Pharm Sci. 2017 Sep 30;107:217-229. doi: 10.1016/j.ejps.2017.07.019. Epub 2017 Jul 17.

PMID:
28728977
10.

Synthesis and biological evaluation of 2-(3,4-dimethoxyphenyl)-6-(2-[18F]fluoroethoxy)benzothiazole ([18F]FEDBT) for PET imaging of breast cancer.

Li GY, Vaulina DD, Li JJ, Fedorova OS, Wang HE, Liu RS, Krasikova RN, Chen CL.

Bioorg Med Chem Lett. 2017 Aug 1;27(15):3460-3463. doi: 10.1016/j.bmcl.2017.05.079. Epub 2017 May 26.

PMID:
28619538
11.

Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles.

Hsieh YC, Cheng TC, Wang HE, Li JJ, Lin WW, Huang CC, Chuang CH, Wang YT, Wang JY, Roffler SR, Chuang KH, Cheng TL.

Sci Rep. 2016 Dec 19;6:39119. doi: 10.1038/srep39119.

12.

Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.

Yang KL, Chang YC, Ko HL, Chi MS, Wang HE, Hsu PS, Lin CC, Yeh DY, Kao SJ, Jiang JS, Chi KH.

Clin Lung Cancer. 2016 Nov;17(6):550-557. doi: 10.1016/j.cllc.2016.05.013. Epub 2016 Jun 8.

PMID:
27378175
13.

Monitoring Tumor Response after Liposomal Doxorubicin in Combination with Liposomal Vinorelbine Treatment Using 3'-Deoxy-3'-[18F]Fluorothymidine PET.

Wu CY, Tang JH, Chan PC, Li JJ, Lin MH, Shen CC, Liu RS, Wang HE.

Mol Imaging Biol. 2017 Jun;19(3):408-420. doi: 10.1007/s11307-016-1005-2.

PMID:
27730471
14.

Involvement of let-7 microRNA for the therapeutic effects of Rhenium-188-embedded liposomal nanoparticles on orthotopic human head and neck cancer model.

Lin LT, Chang CY, Chang CH, Wang HE, Chiou SH, Liu RS, Lee TW, Lee YJ.

Oncotarget. 2016 Oct 4;7(40):65782-65796. doi: 10.18632/oncotarget.11666.

15.

In vitro comparison of conventional hyperthermia and modulated electro-hyperthermia.

Yang KL, Huang CC, Chi MS, Chiang HC, Wang YS, Hsia CC, Andocs G, Wang HE, Chi KH.

Oncotarget. 2016 Dec 20;7(51):84082-84092. doi: 10.18632/oncotarget.11444.

16.

Simultaneous activation and inhibition of autophagy sensitizes cancer cells to chemotherapy.

Chi KH, Wang YS, Huang YC, Chiang HC, Chi MS, Chi CH, Wang HE, Kao SJ.

Oncotarget. 2016 Sep 6;7(36):58075-58088. doi: 10.18632/oncotarget.10873.

17.

Preparation and characterization of a novel Al(18)F-NOTA-BZA conjugate for melanin-targeted imaging of malignant melanoma.

Chang CC, Chang CH, Lo YH, Lin MH, Shen CC, Liu RS, Wang HE, Chen CL.

Bioorg Med Chem Lett. 2016 Aug 15;26(16):4133-9. doi: 10.1016/j.bmcl.2016.06.022. Epub 2016 Jun 9.

PMID:
27445169
18.

Targeted antitumor prodrug therapy using CNGRC-yCD fusion protein in combination with 5-fluorocytosine.

Li JJ, Chang SF, Liau II, Chan PC, Liu RS, Yen SH, Wang HE, Chang CA.

J Biomed Sci. 2016 Jan 22;23:15. doi: 10.1186/s12929-016-0227-6.

19.

¹¹¹In-DOTA-Annexin V for imaging of apoptosis during HSV1-tk/GCV prodrug activation gene therapy in mice with NG4TL4 sarcoma.

Lin MH, Wu SY, Wang HE, Liu RS, Chen JC.

Appl Radiat Isot. 2016 Feb;108:1-7. doi: 10.1016/j.apradiso.2015.11.017. Epub 2015 Dec 1.

PMID:
26656427
20.

Development and Characterization of the Recombinant Human VEGF-EGF Dual-Targeting Fusion Protein as a Drug Delivery System.

Li JJ, Lan KL, Chang SF, Chen YF, Tsai WC, Chiang PH, Lin MH, Fischer WB, Shih YS, Yen SH, Liu RS, Tsay YG, Wang HE, Chang CA.

Bioconjug Chem. 2015 Dec 16;26(12):2481-96. doi: 10.1021/acs.bioconjchem.5b00509. Epub 2015 Nov 24.

PMID:
26525951

Supplemental Content

Loading ...
Support Center